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Platelet-derived growth factors (PDGF) regulate cell proliferation, survival, morphology, and migration, as well as deposition
and turnover of the extracellular matrix. Important roles for the A form of PDGF (PDGF-A) during connective tissue
morphogenesis have been highlighted by the murine Patch mutation, which includes a deletion of the a subunit of the
DGF receptor. Homozygous (Ph/Ph) embryos exhibit multiple connective tissue defects including cleft face (involving the
rst branchial arch and frontonasal processes), incomplete heart septation, and heart valve abnormalities before they die in
tero. Analyses of the cell biology underlying the defects in Ph/Ph embryos have revealed a deficit in a matrix
metalloproteinase (MMP-2) and one of its activators (MT-MMP) that are likely to be involved in cell migration and tissue
remodeling, two processes necessary for normal cardiac and craniofacial development. Morphogenesis of these structures
requires infiltration of ectomesenchymal precursors and their subsequent deposition and remodeling of extracellular matrix
components. First branchial arch and heart tissue from E10.5 embryos were examined by gelatin zymography and RT-PCR
in order to characterize the expression of MMPs in these tissues. Of the MMPs examined, only MMP-2 and one of its
activators, MT-MMP, were expressed in the first arch and heart at this stage of development. Tissues from Ph/Ph embryos
exhibited a significant decrease in both MMP-2 and MT-MMP compared to tissues from normal embryos of the same
developmental stage. In order to assess whether this decrease affects the motile activity of mesenchymal cells, cell
migration from Ph/Ph branchial arch explants was compared to migration from normal arch tissue and found to be
significantly less. In addition, the migratory ability of branchial arch cells from normal explants could be reduced in a
similar manner using a specific MMP inhibitor. Although it is still unclear whether the MMP-2 reduction is a direct result
of the absence of response of Ph/Ph cells to PDGF-A treatment of normal branchial arch cells in vitro with recombinant
PDGF-AA significantly upregulated MMP-2 protein. Together, these results suggest that PDGF-A regulates MMP-2
expression and activation during normal development and that faulty proteinase expression may be at least partially
responsible for the developmental defects exhibited by Ph/Ph embryos. © 1999 Academic Press
Key Words: PDGF; PDGF-a receptor; Patch mice; mouse embryos; MMP-2; cranial neural crest; heart development;
craniofacial development; connective tissue; cell migration; ectomesenchyme.
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pINTRODUCTION
During early vertebrate embryogenesis, neuroepithelial
cells from the cranial neural folds (i.e., the cranial neuralo
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All rights of reproduction in any form reserved.rest) undergo an epithelial-to-mesenchymal transition and
igrate into the developing face and heart. Like those
erived from trunk neural crest, cranial neural crest cells
ocalize at sites where they form neurons and glia of the
eripheral nervous system in addition to a wide variety of
ther derivatives. However, a subset of cranial crest cells
as the unique ability to differentiate into mesenchyme (i.e.
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256 Robbins et al.ectomesenchyme) which later forms cartilage, bone, and
other connective tissues of the head and neck, as well as
discrete structures of the heart (Kirby, 1983; Nichols, 1986;
Kontges and Lumsden, 1996). In particular, we are inter-
ested in those neural crest cells that (1) migrate into the
first branchial arch, where they participate in morphogen-
esis of the mandible and maxilla, and (2) enter the outflow
tract of the heart where they contribute to formation of the
aorticopulmonary septum. The critical events involved in
these processes include effective migration of the cells from
the dorsal aspect of the neural tube to appropriate sites,
adequate cell proliferation to ensure tissue growth, synthe-
sis and secretion of extracellular matrix (ECM) molecules
that contribute to specific connective tissues, and degrada-
tion of these ECM molecules as the structures in question
grow and change composition. Very little is known, how-
ever, about the intrinsic factors that may regulate these
events. Gaining such knowledge is important not only for
elucidating the course of normal development, but also for
understanding the etiology of relatively common human
craniofacial and cardiac birth defects.
An intriguing way of studying regulation of specific
developmental events is with animals carrying naturally
occurring or targeted gene deletions. One such animal is the
Patch mutant mouse, which carries a deletion of the entire
coding region of the a subunit of the platelet-derived
rowth factor (PDGF) receptor (PDGFRa; Gruneborg and
Truslove, 1960; Stephenson et al., 1991). PDGFRa binds
both the A and the B chains of PDGF, and the ability to
respond to the A form of PDGF is completely absent in
homozygous recessive (Ph/Ph) embryos. Although these
embryos can respond to PDGF-B when the b receptor
ubunit begins to be expressed at embryonic day (E; days
ostcoitum) 7.5 (Mercola et al., 1990), this form of the
rowth factor appears to be involved in later developmental
vents (Morrison-Graham et al., 1992). Ph/Ph embryos
xhibit numerous defects of craniofacial, heart, and axial
onnective tissue, including connective tissues derived
rom ectomesenchyme, before they die in utero (Morrison-
raham et al., 1992; Orr-Urtreger et al., 1992; Schatteman
t al., 1992). Although the Patch deletion is quite large
Stephenson et al., 1991), the cause of connective tissue
efects in Ph/Ph embryos (i.e., absence of the PDGFRa) has
been confirmed in PDGFRa-null mice (Soriano, 1997). The
defects on which we focus here are the cleft face, small
mandible, and defective aorticopulmonary septum, all of
which may result from faulty migration and/or differentia-
tion of specific populations of cranial neural crest cells
which normally express elevated levels of PDGFRa. Impor-
tantly, similar defects also arise in human embryos. These
include clefts of the lip and palate, which result from failure
of specific facial processes to develop properly and fuse;
mandibular dysostosis, which involves hypoplasia of the
musculoskeletal derivatives of the first and second
branchial arches; and abnormalities of cardiac septa (Van
Mierp et al., 1962; Poswillo, 1988). Although the defects of
Ph/Ph embryos have been described in detail, the cell
e
f
Copyright © 1999 by Academic Press. All rightbehaviors underlying them remain obscure. Thus, Ph/Ph
embryos provide an excellent opportunity to study the
behavior of specific populations of cells in the absence of a
response to PDGF-A and to determine whether this leads to
alterations in expression of other molecules which may also
contribute to the observed defects.
Because it seems likely that migration of cranial neural
crest cells, and/or the ability of their mesenchymal deriva-
tives to remodel developing structures, is affected by the
Patch mutation, we have asked whether expression or
activity of extracellular proteases is altered in Ph/Ph em-
bryos and whether such an alteration could account, at least
in part, for the facial and heart defects in these embryos.
Regulated expression of extracellular proteases is required
for cell movements through ECM, for cell shape changes
during differentiation, and for cellular remodeling of ECM
as development progresses (Hewitt et al., 1996; Kinoh et al.,
1996). The matrix metalloproteinases (MMPs) are a family
of such enzymes that can selectively degrade at least one
ECM component (Parsons et al., 1997). MMPs are secreted
in a latent form and their activity is controlled by specific
activators and inhibitors (Woessner, 1991). They may be
sequestered in the ECM or bound to cell surfaces and are
suspected to play critical roles in any physiological event
that requires cell migration or tissue remodeling (e.g.,
wound healing, tumor cell invasion, bone resorption, and
morphogenesis). We have found that two MMPs, MMP-2
and MT-MMP (an activator of MMP-2), are selectively
underexpressed in branchial arch and heart tissue from
Ph/Ph embryos. This deficit may result in impaired motile
activity of mesenchymal cells as suggested by the failure of
cells in Ph/Ph branchial arches to migrate on gelatin sub-
strata as their wild-type counterparts do. Our results pro-
vide the first definitive insights into the mechanisms by
which the developmental abnormalities in Ph/Ph embryos
may arise and raise approachable questions concerning the
functional relationships among molecules required for
these events to occur normally.
MATERIALS AND METHODS
Embryos
An inbred colony of heterozygous (Ph/1) Patch mice (C57BL/6
ackground) was established and maintained through a continuous
egimen of sibling matings (a generous gift from Dr. James Weston,
niversity of Oregon). Members of this colony were mated with
alb/cGn mice to obtain an outbred generation. Siblings of this
ating were, in turn, mated to produce the timed-pregnant females
rom which homozygous (Ph/Ph) and normal embryos were ob-
ained for this study. Additional normal embryos were obtained by
ating wild-type (1/1) outbred hybrid siblings, producing em-
ryos which were of the same genetic background as the Patch
mbryos. Embryonic day (E) 0 was judged to be 12 h prior to the
orning on which a vaginal plug was observed. Tissues used in this
tudy (first branchial arch, heart, and tail) were dissected from
mbryos, frozen on dry ice, and stored at 270°C until needed for
urther analysis.
s of reproduction in any form reserved.
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257MMP-2 Reduction in Patch Mutant MiceGenotyping
Mutant embryos were identified by the absence of the PDGFRa
gene by PCR analysis and were designated (Ph/Ph). All others were
designated “normal” and included both wildtype (1/1) and het-
erozygotes (Ph/1) as described above. Frozen tail tissue was thawed
in 50 ml of a DNA extraction buffer of 10 mM Tris, pH 7.4, 2.0 mM
DTA, and 0.2% Triton X-100. Proteinase K (Boehringer Mann-
eim, Indianapolis, IN) was added to a final concentration of 200
mg/ml, and the samples were heated to 55°C for 3 h. Finally, the
samples were boiled at 100°C for 5 min. Two microliters of each
sample was used in a standard PCR at 94°C for 1 min, 60°C for 1
min, 72°C for 1 min for 27 cycles. The following primers for mouse
PDGFRa were used: forward, ACC TCC TTT CGG ACG ATG AC,
reverse, ATC ACT TCA GAA TGG CTC CA. Reactions were
analyzed using ethidium bromide-stained agarose gels.
RT-PCR
Total RNA was prepared from the first branchial arch, including
the maxillary and mandibular processes, and from the entire heart,
including the inflow and outflow tracts. The frozen tissue was
thawed in 500 ml Trizol reagent (Gibco BRL, Gaithersburg, MD)
nd total RNA prepared utilizing the manufacturer’s instructions.
DNA was prepared from 1–2 mg of total RNA using an oligo(dT)
rimer and Superscript reverse transcriptase (Gibco BRL). One
icroliter of each first-strand reaction was amplified using a
tandard PCR (see above) using the primers for MMP-2 (forward,
TC TAC TTG CTG GAC ATC AGG GGG, reverse, TGG CTC
AA ATT CAC AAG GTC C), for MMP-3 (forward, TGT ACC
AG TCT ACA AGT CCT CCA, reverse, CTG CGA AGA TCC
CT GAA GAA GTA G), for MMP-7 (forward, ACT GGA AAA
TC TCC CCC TAC ATC, reverse, TGC AGA CCG TTT CTG
GA TCT G), for MMP-9 (forward, TGC GAC CAC ATC GAA
TT CG, reverse, CCA GAG AAG AAG AAA ACC CTC TTG G),
nd for MT-MMP (forward, GTG ATG GAT GGA TAC CCA ATG
, reverse, GAA CGC TGG CAG TAA AGC AGT C). Primers for
8S rRNA were purchased from Ambion (Austin, TX). The MMP
rimers were designed from the full-length mouse MMP sequences
sing the MacVector Sequence Analysis Program 5.0 (Oxford
olecular Group PLC, 1996). The primers were tested utilizing
ositive control RNA isolated from postpartum mouse uterine
issue, which expresses all five of the MMPs analyzed in this study
Rudolph-Owen et al., 1977). In preliminary experiments, the
conditions used for PCR amplification were determined to be
within the linear range of product amplification by quantitating the
amount of product produced at every fifth cycle between 5 and 35
cycles. Quantitation of ethidium bromide-stained bands in agarose
gels was accomplished by digitizing the gels and then quantitating
the signal intensity of individual bands utilizing NIH Image.
Values for expression of each of the genes were normalized to the
level of signal intensity for 18S to control for differences in the
amount of starting RNA in each sample. Analyses were repeated
twice on separate RNA isolates.
Zymography
Individual branchial arches and hearts were extracted in 50 ml of
0.1 M phosphate buffer, pH 7.4, containing 0.1% Triton X-100
nd extracted overnight at 4°C. Aliquots of each sample were
ubjected to electrophoresis in 10% SDS–polyacrylamide gels into
hich gelatin (1 mg/ml) had been crosslinked. Following electro-
horesis the gels were soaked for 15 min in 2.5% Triton X-100 and
Copyright © 1999 by Academic Press. All rightrinsed with water. The gels were incubated for 48 h in LSCB buffer
(50 mM Tris, pH 7.6, 0.2 M NaCl, 5 mM CaCl2 0.02% Brij 35, and
0.02% NaN3) at 37°C. Following incubation, the gels were stained
or 1 h with 0.125% Coomassie blue and destained with 10% acetic
cid. The stained gels were digitized, and the zones of proteolysis,
orresponding to the presence of proteases in the gel, were quanti-
ated using NIH Image. Identification of the 72- and 62-kDa forms
f MMP-2 was determined by comparison of the migratory position
f the bands with known MMP-2 standards (Zucker et al., 1994).
NA contents of each extract were obtained using a spectrofluo-
imeter, and values for MMP-2 were normalized to the DNA
ontent to control for discrepancies in the amount of tissue in each
ample and to determine the amount of MMP-2/cell number.
Explant Cultures
First branchial arch tissue from E10.5 embryos was minced into
small (#1 mm2) pieces and explant cultures were established by
culturing the pieces on gelatin-coated coverslips for motility anal-
ysis or in 35-mm2 gelatin-coated culture dishes for the PDGF
addition experiments. The motility analysis was carried out by
maintaining the tissue in F12 medium supplemented with 10%
FCS and 1000 U/ml Pen/Strep (Gibco BRL). Inhibitor experiments
were carried out by preparing a 10 mM stock solution of the matrix
metalloproteinase inhibitor (KB8301; a nonselective inhibitor of all
metalloproteinases [4-(N-hydroxyamino)-2R-isobutyl-3S-methyl-
succinyl]-L-3-(5,6,7,8-tetrahydro-1-naphyhyl)alanine-N-methylam-
ide; Pharmingen, San Diego, CA) in DMSO. The inhibitor was
added to the cultures to a final concentration of 10, 50, or 200 mM,
and equivalent concentrations of DMSO not containing KB3801
were added to some cultures. Following a 24-h culture period,
images of the explant and associated cells were obtained and
quantitated for the extent of cellular outgrowth using the Meta-
morph Image Analysis System (Universal Imaging, West Chester,
PA). The extent of cell migration was determined by measuring the
radial distance from the edge of the explant to the farthest cells at
six consistent points around the circumference of the explant. Data
were expressed as average micrometers from the edge of the explant
and analyzed statistically using a Student t test.
PDGF addition experiments were carried out in cultures main-
tained in F12 medium containing 1% ITS1 and 1000 U/ml Pen/
Strep. A 1 mg/ml stock solution of recombinant human PDGF-AA
(R & D Systems, Minneapolis, MN) was prepared in PBS containing
1% (w/v) BSA. The growth factor was added to the cultures to a
final concentration of 10 or 100 ng/ml. Twenty-four hours later, the
tissue pieces were washed three times with PBS and then extracted
in 50 ml of a 0.1 M phosphate buffer, pH 7.4, containing 0.1%
Triton X-100. The extracts were analyzed by gelatin zymography
(see above). Unless otherwise mentioned, all reagents used in this
study were purchased from Sigma Chemical Company (St. Louis,
MO).
RESULTS
MMP Expression and Activity in Normal Mouse
Embryos
In order to determine which MMPs are present in mouse
first branchial arch and heart tissues during a relevant
period of embryogenesis, both tissues were examined by
gelatin zymography at E10.5 (Fig. 1A). Extracts were pre-
s of reproduction in any form reserved.
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258 Robbins et al.pared from the first branchial arch, including both the
maxillary and the mandibular processes, and from whole
heart, including the inflow and outflow tracts. In both
tissues, MMP-2 (gelatinase A) was the only MMP detected,
being present in the inactive 72-kDa pro-form and the
proteolytically activated 62-kDa form. Other MMPs which
can also be detected with this analysis, including MMP-9
(gelatinase B), were not observed in either tissue at this
stage of development.
RT-PCR was used to determine which MMP genes are
expressed in arch and heart tissue at this developmental
stage (Figs. 1B and 1C). Total RNA prepared from each
tissue was transcribed into cDNA and subsequently used in
PCR utilizing primers for MMP-2, 3, 7, and 9 and MT-MMP
(the membrane-bound MMP which proteolytically acti-
vates MMP-2). In both tissues, expression of MMP-2 and
MT-MMP was easily detectable. Expression of MMP-3, 7,
and 9, however, was not observed in either tissue.
MMP-2 Activity and Expression Are Reduced
in Ph/Ph Branchial Arch and Heart
FIG. 1. Gelatinase activity and MMP expression in first branchial
arch and heart tissues. (A) Representative gelatin zymography of
tissue extracts from E10.5 normal (1/1) embryos. Lane 1, extract of
rst branchial arch; lane 2, extract of whole heart. The positions of
he 72-kDa pro- and 62-kDa active forms of MMP-2 are indicated at
he left. Confirmation of these bands as the pro- and active forms of
MP-2 was established by their comigration with known MMP-2
tandards (see Materials and Methods). (B and C) Representative
T-PCR analysis of MMP expression in branchial arch and heart,
espectively. RNA was prepared from first branchial arch (B) and
hole heart (C) from E10.5 normal (1/1) embryos and used in a
everse transcription reaction. First-strand cDNA was subse-
uently amplified by PCR with the following primers: MMP-2 (lane
), MMP-3 (lane 3), MMP-7 (lane 4), MMP-9 (lane 5), MT-MMP
lane 6) and 18S rRNA (lane 7). (Lane 1) DNA ladder. All of the
rimers used were tested with positive control RNA isolated from
ostpartum mouse uterine tissue, which expresses all five of the
MPs analyzed in this study.All embryos used in the experiments reported were
genotyped by PCR utilizing genomic DNA and primers for
a
i
Copyright © 1999 by Academic Press. All rightDGFRa. Extracts of the first branchial arch and heart from
h/Ph and normal (Ph/1 and 1/1) embryos were analyzed
y gelatin zymography. Figure 2 is a representative zymo-
ram of heart tissue extracts from a single litter of E10.5
mbryos and demonstrates significantly diminished levels
f MMP-2 in the Ph/Ph embryos compared to the normal
ittermates. Normalized values for MMP-2 were then com-
ared between these two groups to quantify the apparently
ltered levels of MMP-2 seen in the Ph/Ph embryos. In
h/Ph embryos, the pro- and active forms of MMP-2 in
ranchial arch tissue were significantly reduced by 60 and
0%, respectively, compared to normal embryos (Fig. 3A).
nalysis of MMP expression in branchial arch tissue by
T-PCR showed a similar reduction in the level of MMP-2
RNA (Fig. 3B). Even more striking was a 95% reduction in
he level of expression of MT-MMP, the activator of
MP-2, in Ph/Ph embryos compared to normal embryos.
Heart tissue from Ph/Ph embryos showed a similar reduc-
ion in the level of the 72- and 62-kDa forms of MMP-2
ompared to the same tissue in normal embryos (Fig. 3C).
nalysis of MMP-2 and MT-MMP expression by RT-PCR
nalysis also showed significant reductions in the level of
xpression of both proteinases in Ph/Ph embryos (Fig. 3D).
Cells from Ph/Ph Branchial Arch Exhibit Impaired
Migratory Ability
In light of the critical role MMPs are believed to play in
cell migration, studies were performed to determine
whether crest-derived mesenchymal cell migration was
impaired in Ph/Ph embryos. Branchial arch tissue from
normal and Ph/Ph E10.5 embryos was minced into small
(,1 mm2) pieces and cultured on gelatin-coated coverslips
or a period of 24 h. Tissue pieces from individual embryos
ere cultured separately and the remainder of the embryos
ere subsequently genotyped. Arch tissue from normal
nimals adhered well to the gelatin-coated substratum, and
fter 16 to 24 h a substantial number of polygonal-shaped
FIG. 2. MMP-2 is reduced in the first branchial arch of Ph/Ph
mbryos. Representative zymogram of first branchial arch extracts
rom a litter of E10.5 embryos. A significant reduction in the
mount of MMP-2, both pro- and active forms, can be appreciated
n homozygous (Ph/Ph) embryos compared to normal littermates.
s of reproduction in any form reserved.
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259MMP-2 Reduction in Patch Mutant Micecells had migrated out from the tissue and formed large
“halos” around the explants (Fig. 4A). The pattern of
outgrowth from Ph/Ph explants was markedly different
(Fig. 4B). While the tissue from the Ph/Ph embryos adhered
well to the gelatin-coated surface, many fewer cells mi-
grated out of the explant. The extent of migration was
quantified by measuring the average distance the cells
moved from the edge of the explant in a 24-h period. As seen
in Table 1, branchial arch cells from normal embryos
migrated nearly four times farther on the culture substra-
tum compared to those from Ph/Ph mutant embryos. In
addition, the presence of DMSO in the cultures had no
apparent adverse affect on the migratory ability of the
normal cells.
In order to assess whether the impaired migratory ability
of Ph/Ph cells was due to inadequate MMP-2 activity,
explants of branchial arch tissue from normal wild-type
embryos were cultured in the presence of the synthetic
FIG. 3. MMP-2 activity and expression in branchial arch and hea
MP-2 activity in extracts of first branchial arch and heart tissue,
Values represent the mean areas of the lysis zones and are expressed
mbryos. *Significantly different at the P # 0.05 level by Student
T-MMP expression in arch and heart tissue, respectively, from Ph
ntensities of ethidium bromide-stained bands expressed as a percemetalloproteinase inhibitor, KB3801. Addition of KB3801
to the cultures resulted in a dose-dependent decrease in cell d
Copyright © 1999 by Academic Press. All rightmigration, and when it was added to a final concentration of
200 mM, the average distance of migration was reduced by
nearly 10-fold (Fig. 4C and Table 1). The inhibition of MMP
activity in the explant cultures by KB3801 was confirmed
by analyzing treated and untreated explants by zymogra-
phy. Explants incubated for 24 h with increasing concen-
trations of KB3801 demonstrated a dose-dependent reduc-
tion in the level of activated (62 kDa) MMP-2 (Fig. 5). No
significant change was seen in the level of the proenzyme in
response to the addition of inhibitor. This result suggests
that MT-MMP was sensitive to the effects of KB3801, in
addition to the active form of MMP-2.
PDGF-AA Stimulates Increased MMP-2 Synthesis
in Explants of Normal Arch Tissue
The next experiments addressed whether MMP-2 levels
in the branchial arch could be regulated by PDGF-A, thus
sue from normal and Ph/Ph embryos. (A and C) Quantification of
ectively, from E10.5 Ph/Ph and normal (Ph/1 or 1/1) littermates.
e percentage of control, 6 SEM, for n 5 7 control and n 5 7 normal
test. (B and D) Semiquantitative RT-PCR analysis of MMP-2 and
nd normal (Ph/1 or 1/1) littermates. Normalized values represent
e of control.rt tis
resp
as th
’s tproviding a link between loss of PDGFRa signaling and
ecreased levels of MMP-2 in Ph/Ph embryos. Branchial
s of reproduction in any form reserved.
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260 Robbins et al.arch explants from normal embryos were treated with
FIG. 4. Mesenchymal cell migration from branchial arch explants
s reduced in Ph/Ph embryos and is dependent upon MMP-2
activity. Explants of first branchial arch tissue from normal (1/1)
embryos (A), from Ph/Ph embryos (B), and from normal (1/1)
mbryos cultured in the presence of the synthetic MMP inhibitor
B3801 (200 mM) (C). E, explant. Bar, 100 mm.either 10 or 100 ng/ml recombinant PDGF-AA for 24 h and
the tissue was subsequently analyzed by zymography. Sig-
Copyright © 1999 by Academic Press. All rightificant increases were seen in both the pro- and the active
orms of MMP-2 in branchial arch tissue treated with 100
g/ml PDGF (Fig. 6). While these experiments showed that
MP-2 protein levels were elevated by PDGF-AA, RT-PCR
nalysis did not show a similar increase of MMP-2 mRNA.
ollowing treatment at either concentration of PDGF-AA,
ignificant differences in MMP-2 mRNA were not observed
data not shown). These data suggest that PDGF-A may
egulate MMP-2 synthesis at a posttranscriptional level or
hat the growth factor stimulates a transient increase in
MP-2 mRNA which is no longer detectable at 24 h.
DISCUSSION
The dramatic reduction in MMP-2 and one of its activa-
tors, MT-MMP, in defective tissues of Ph/Ph embryos
strongly suggests a role for this extracellular proteinase in
normal morphogenesis. The fact that cells in these embryos
cannot respond to PDGF-A raises the possibility that there
is normally a link between this response and MMP-2
ABLE 1
Animal treatment
condition
Avg. dist. (mm) of cell migration
from edge of explant (6 SEM)
Normal (w/o DMSO) 287 (46)
Ph/Ph 75 (5)*
Normal (1200 mM DMSO) 238 (39.6)
10 mM KB3801 78.3 (5.8)*
0 mM KB3801 66.8 (11.6)*
00 mM KB3801 29.0 (9.35)*
* Statistical significance at a level #0.5, Student’s t test. For
ormal and Ph/Ph samples, n 5 7 embryos. For normal samples and
amples with added KB3801, n $ 4 explants.
FIG. 5. Activation of MMP-2 is inhibited in branchial arch tissue
by the matrix metalloproteinase inhibitor KB3801. Explants of first
branchial arch tissue from normal (1/1) control, E10.5 embryos
were incubated with increasing concentrations of KB3801 and
analyzed by zymography. Values are the areas of the lysis zones for
individual cultures.
s of reproduction in any form reserved.
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261MMP-2 Reduction in Patch Mutant Miceexpression, and this is supported by our in vitro studies
demonstrating that PDGF-A can, indeed, regulate MMP-2.
We have focused our analyses on the craniofacial and heart
defects in the mutant embryos, due to our interest in
understanding the mechanisms underlying migration and
differentiation of cranial neural crest-derived mesenchymal
cells (ectomesenchyme). In normal embryos, derivatives of
this subpopulation of crest cells express high levels of
PDGFRa, including branchial arch mesenchyme and cush-
on tissue of the heart (Morrison-Graham et al., 1992;
rr-Urtreger et al., 1992; Schatteman et al., 1995), and the
facial and heart defects of Ph/Ph mice suggest that PDGF-A
is involved in initial localization of cranial crest cells
and/or their subsequent expression of a mesenchymal phe-
notype. The reduction in MMP-2 in Ph/Ph mice could at
least partially account for perturbations in either of these
events.
A population of neuroepithelial cells of the cranial neural
folds undergoes an epithelial-to-mesenchymal transition
and then follows stereotyped pathways into the branchial
arches, outflow tract of the heart, and other sites at which
they differentiate (e.g., LeDouarin, 1982; Kirby et al., 1983;
Tan and Morriss-Kay, 1985). Neural crest cells express
MMPs and other proteinases in vitro (Valinsky and Le-
Douarin, 1985; Duong and Erickson, 1995; Agrawal and
Brauer, 1996), and it seems likely that these molecules are
involved in their ability to both emigrate from the neural
tube and invade adjacent mesenchyme in vivo, as has been
shown for other cell types (Matrisian, 1992; Ray and Stetler-
Stevenson, 1994; Chin and Werb, 1997). We and others
(Reponen et al., 1992) have shown that MMP-2 appears to
FIG. 6. PDGF-A regulates MMP-2 levels in branchial arch ex-
plants. Explants of first branchial arch tissue from normal (1/1)
control, E10.5 embryos were treated with 10 or 100 ng/ml recom-
binant PDGF-AA for a period of 24 h. Levels of MMP-2 within the
tissue were analyzed by gelatin zymography and normalized to the
DNA content of the explants to control for sample-to-sample
variability in the amount of tissue used in the analysis. Values
represent mean areas of lysis zones expressed as a percentage of
control values 6 SEM, for n 5 6 explants. *Significantly different at
he P # 0.05 level by Student’s t test.be the only gelatinase expressed in mouse embryos during
the period of crest migration into the branchial arches and
i
m
Copyright © 1999 by Academic Press. All rightheart, and it seems likely that the broad substrate specific-
ity of this enzyme allows crest cells to migrate through a
variety of tissues (Duong and Erickson, 1995). In this study,
we demonstrate that crest-derived mesenchymal cells from
Ph/Ph embryos do not migrate normally in vitro and that
normal cells treated with an MMP inhibitor exhibit simi-
larly diminished migratory ability. Taken together, these
results support the idea that crest migration may be per-
turbed in Ph/Ph embryos, leading to insufficient numbers of
cells at critical locations. An important point in this regard
is that the neuronal and glial crest derivatives in Ph/Ph
mice appear to be normal (Morrison-Graham et al., 1992),
which is not surprising because these cells in normal
animals do not express the PDGFRa. Therefore, migration
f ectomesenchyme precursors is likely to be affected
electively. Although there may be consequences of the
DGFRa defect in addition to perturbation of migration
discussed below), it is of interest that PDGF is known to
ave chemotactic effects on some cell types (Raines et al.,
990), and the recognition of its ability to regulate MMPs
ay have revealed a mechanism for this phenomenon.
The inability of Ph/Ph mesenchymal cells to migrate in
itro is somewhat puzzling as MMP-2, although reduced in
mount, was nevertheless present in the explant cultures.
owever, we have not yet determined the overall level of
MP-2 activity (i.e., activity in the presence of specific
endogenous tissue inhibitors) in either the embryos or the
cultures, and this may be the critical deficit in the mutant
tissues. Regulation of proteolytic activity in tissues is
mediated through interactions between active enzymes and
their specific inhibitors such as TIMP-2 (tissue inhibitor of
metalloproteinase-2). TIMP-2 is a specific inhibitor of
MMP-2 and it is expressed in the first branchial arch prior
to and during crest migration (Chin and Werb, 1997).
Therefore, assessment of enzyme activity levels and inhib-
itor expression will be a crucial next step in evaluating the
impact of diminished MMP-2 in Ph/Ph embryos.
Once ectomesenchyme precursors have arrived in the
branchial arches and heart they contribute to the formation
of connective tissue. ECM molecules are synthesized and
secreted by differentiating crest cells, and the ECM must
undergo changes in its structure and composition as the
face and heart enlarge and change shape. During such tissue
remodeling, matrix metalloproteinases, including MMP-2,
have been shown to be critical to these alterations as
morphogenesis proceeds (Parsons et al., 1997; Chin and
Werb, 1997). They may function to degrade existing ECM
components and also to regulate cell–ECM interactions as
ECM structure changes. Just as inhibition of MMP activity
in the embryonic mouse mandible disrupts its development
(Chin and Werb, 1997), underexpression of MMP-2 may
contribute to the observed defects of Ph/Ph embryos. A
study by Iamaroon et al. (1996) demonstrated intense stain-
ng for MMP-2 at the zone of fusion of the facial promi-
ences in the mouse embryo, suggesting a role for MMP-2
n this process. Reduction of MMP-2 in the Patch mouse
ay affect remodeling of the facial primordia resulting in
s of reproduction in any form reserved.
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262 Robbins et al.the characteristic cleft face seen in the homozygous ani-
mals.
Although our studies and the others cited above indicate
that MMP-2 has important roles in normal development,
knockout mice which do not express MMP-2 develop to
term and produce fertile offspring (Itoh et al., 1997). This
discrepancy might arise from critical differences in the
responses of cells in Ph/Ph and MMP-2-null embryos to
diminished or absent MMP-2. It remains unknown whether
the knockout mice compensate for the complete absence of
MMP-2 through upregulation of other extracellular protein-
ase genes, such as urokinase or other metalloproteinases.
This response would not be as likely to occur in Ph/Ph
embryos, in which at least some MMP-2 is present. In
addition, the MMP-2-null and Ph/Ph mice might be distin-
guished by perturbation in Ph/Ph of additional molecules
that act in concert with MMP-2, such as MT-MMP and/or
TIMPs. The balance of, and interactions among, such mol-
ecules are likely to be more important than the absolute
amount in which each is present.
To our knowledge, this is the first report that MMP-2
synthesis and activity by embryonic cells can be regulated
by PDGF-A. Results from this study also suggest that the
regulation of MMP-2 by PDGF may occur at a posttran-
scriptional level, as no changes were seen in MMP-2 mRNA
in response to PDGF stimulation. A previous study by
Overall et al. (1991) has demonstrated that another growth
factor, TGFb, alters the level of MMP-2 by stabilizing the
RNA for this protein. Whether this is the mechanism by
hich PDGF increases the level of MMP-2 in the embry-
nic branchial arch tissue remains to be determined.
In another study, Kenagy et al. (1997) demonstrated a
ependence of PDGF-induced migration on MMPs in cul-
ures of vascular smooth muscle cells and found that
MP-2 levels in these cultures were decreased by blocking
ntibodies to bFGF and PDGF. The results of that study
irectly support our findings, although the origins of the
ell types in each study were different (i.e., embryonic vs
dult, mesenchymal vs smooth muscle). Additional studies
ddressing the relationship between PDGF and MMPs have
hown that both the A and the B chains of PDGF can
timulate synthesis of MMP-1 and TIMP-1 by a variety of
ell types in vitro (Fabummi et al., 1996; Yang et al., 1989;
Alexander et al., 1989; Alvares et al., 1995). However,
demonstration that one role for PDGF during embryogen-
esis may be regulation of MMPs is particularly important
because PDGFRa is expressed by cells throughout mesen-
hyme (including ectomesenchyme), and mesenchymal
ells must interact with ECM during morphogenesis in a
ariety of ways that require such proteinases. Coexpression
f PDGFRa and MMP-2 during mouse development
Morrison-Graham et al., 1992; Reponen et al., 1992) cer-
ainly supports this idea.
Although we hypothesize that regulation of MMP-2 is a
ritical response of ectomesenchyme to PDGF-A, we recog-
ize that this growth factor has other critically important
ffects on embryonic cell behavior. The potent mitotic
Copyright © 1999 by Academic Press. All rightction of PDGF has been widely known for many years
Raines et al., 1990), and expression of PDGFRa in embry-
nic mesenchyme certainly suggests that it may regulate
ell proliferation in those locations. While there did not
ppear to be a deficit in proliferation of cells in defective
tructures of PDGFRa-null embryos, increased apoptosis in
the branchial arches was noted (Soriano, 1997), although its
extent is difficult to assess. We plan to examine this issue
closely in Ph/Ph embryos, as alterations in either of these
processes could contribute to the observed craniofacial and
heart defects. In addition, there have been limited reports of
PDGF regulation of ECM synthesis (Raines et al., 1990), a
question that we are currently addressing in our laborato-
ries. Thus, PDGF might regulate aspects of ECM deposition
during growth and remodeling of the branchial arches and
heart and/or its degradation and turnover via effects on
MMP expression or activity.
In summary, we suggest that regulation of MMP-2 is one
important effect of PDGF-A on migrating and/or differenti-
ating mesenchymal cells during normal development and
that perturbation of this effect in Ph/Ph embryos, which are
unable to signal through the a receptor for this growth
factor, contributes to the extensive connective tissue ab-
normalities that they exhibit. We have focused on ectomes-
enchymal cells that arise from the cranial neural folds and
contribute to structures of the developing face and heart, as
these cells must migrate to appropriate sites at which their
derivatives express and remodel ECM. Having demon-
strated a dramatic reduction in MMP-2 levels in the first
branchial arch and heart, we must now determine precisely
which aspects of crest cell behavior this deficit affects in
vivo. These questions are of paramount interest in elucidat-
ing the bases of human craniofacial and heart defects,
several of which are closely analogous to those exhibited by
Ph/Ph embryos (Van Mierop et al., 1962; Poswillo, 1988).
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